Members |
targetComponentId |
Tongue diseases NOS |
Disorder of tongue (disorder) |
Tongue flap |
Flap (substance) |
Tonic-clonic epilepsy |
A disease of the brain characterized by an enduring predisposition to generate epileptic seizures. |
Tonsil (& peritonsillar region) |
Palatine tonsillar structure |
Tonsil/adenoid operation NOS |
Operations on tonsil and adenoid |
Tonsil/adenoid operation NOS |
Operations on tonsil and adenoid |
Tooth and gingiva operations NOS |
Tooth and gingiva operations |
Tooth and gingiva operations NOS |
Tooth and gingiva operations |
Tooth attrition |
Excessive attrition of teeth |
Tooth decalcification |
Incipient enamel caries |
Tooth eruption disturbances NOS |
Tooth eruption disorder (disorder) |
Tooth removal NOS |
Tooth extraction |
Tooth removal NOS |
Tooth extraction |
Tooth restoration NOS |
Restoration of tooth |
Tooth restoration NOS |
Restoration of tooth |
Tooth symptom NOS |
Tooth symptoms |
Tooth symptom NOS |
Tooth symptoms |
Top manager - business NOS |
Top manager - business |
Top manager - business NOS |
Top manager - business |
Topical anesthesia for procedure on eye |
Administration of anesthesia (procedure) |
Topical anesthetic |
Local anesthetic (substance) |
Topical compound dexamethasone preparation allergy |
Allergy to dexamethasone |
Topical compound hydrocortisone preparation allergy |
Allergy to hydrocortisone (finding) |
Topical corticosteroid, group I |
Glucocorticoid (substance) |
Topical corticosteroid, group II |
Glucocorticoid (substance) |
Topical corticosteroid, group III |
Glucocorticoid (substance) |
Topical corticosteroid, group IV |
Glucocorticoid (substance) |
Topical corticosteroid, group V |
Glucocorticoid (substance) |
Topical corticosteroid, group VI |
Glucocorticoid (substance) |
Topical dermatological preparation adverse reaction |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
Topical dexamethasone allergy |
Allergy to dexamethasone |
Topical estradiol allergy |
Allergy to estradiol (finding) |
Topical hydrocortisone allergy |
Allergy to hydrocortisone (finding) |
Topical prednisolone allergy |
Allergy to prednisolone |
Topical salicylic acid allergy |
Allergy to salicylic acid (finding) |
Topical selenium |
Selenium |
Topical sulfur |
Sulfur |
Topotecan 1mg powder for infusion solution vial |
Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial |
Torday's elephant shrew |
Family Macroscelididae |
Torek operation for orchiopexy |
Orchidopexy |
Torsemide 10mg/mL injection solution ampule |
Product containing only torasemide in parenteral dose form (medicinal product form) |
Torulopsis |
Candida |
Torulopsis candida |
Candida saitoana |
Torulopsis glabrata |
Nakaseomyces glabratus (organism) |
Torulopsis pintolopesii |
Candida pintolopesii |
Total biopterins |
Substance with biopterin structure (substance) |
Total colectomy, ileostomy and creation of rectal fistula however further qualified |
Total colectomy, ileostomy and rectal mucous fistula (procedure) |
Total estimated daily energy intake |
The approximate intake in one day of all energy. |
Total excision of bladder NOS |
Complete cystectomy |
Total excision of bladder NOS |
Complete cystectomy |
Total excision of organ NOC |
Complete excision and removal of an entire body organ |
Total excision of stomach NOS |
Total gastrectomy |
Total excision of stomach NOS |
Total gastrectomy |
Total prosthetic replacement of hip joint not using cement NOS |
Uncemented prosthetic total arthroplasty of hip joint |
Total prosthetic replacement of hip joint using cement NOS |
Cemented prosthetic total arthroplasty of hip joint (procedure) |
Total white cell count NOS |
White blood cell count |
Total white cell count NOS |
White blood cell count |
Tourette's disorder |
Gilles de la Tourette's syndrome |
Town planner/architect NOS |
Architect AND/OR town planner |
Town planner/architect NOS |
Architect AND/OR town planner |
Toxemia of pregnancy |
Pre-eclampsia (disorder) |
Toxic effect |
Interference in normal bodily functions caused by exposure through ingestion, inhalation, absorption, or injection of a substance (e.g. medicinal product, household product, industrial chemical, or plant or animal derivatives) in quantities that are harmful to health. |
Toxic effect from eating shellfish |
Toxic effect from eating shellfish (disorder) |
Toxic effect from noxious substance eaten as food, NEC |
Food poisoning (disorder) |
Toxic effect of chiefly nonmedicinal substance, NEC |
Toxic effect of chiefly nonmedicinal substance |
Toxic effect of hydrocarbon gas, NEC |
Toxic effect of hydrocarbon gas (disorder) |
Toxic effect of nitroderivatives and aminoderivatives of benzene and its homologues |
Poisoning caused by substance with benzene structure (disorder) |
Toxic effect of non-petroleum-based solvent |
Toxic effect of nonpetroleum-based solvent |
Toxic effect of noxious substance eaten as food |
Food poisoning (disorder) |
Toxic effect of other nonpetroleum-based solvent, NEC |
Toxic effect of nonpetroleum-based solvent |
Toxic effect of tobacco and nicotine |
Nicotine poisoning |
Toxic effects - substances NOS |
Interference in normal bodily functions caused by exposure through ingestion, inhalation, absorption, or injection of a substance (e.g. medicinal product, household product, industrial chemical, or plant or animal derivatives) in quantities that are harmful to health. |
Toxic effects - substances NOS |
Interference in normal bodily functions caused by exposure through ingestion, inhalation, absorption, or injection of a substance (e.g. medicinal product, household product, industrial chemical, or plant or animal derivatives) in quantities that are harmful to health. |
Toxic encephalopathy |
Toxic encephalopathy |
Toxic liver disease with acute hepatitis |
Acute toxic hepatitis |
Toxic liver disease with cholestasis |
Drug-induced intrahepatic cholestasis |
Toxic nephropathy, not elsewhere classified |
Toxic nephropathy |
Toxic nephropathy, not elsewhere classified |
Toxic nephropathy |
Toxic noninfectious hepatitis |
Toxic hepatitis |
Toxic porphyria, NEC |
Porphyria caused by toxic effect of substance (disorder) |
Toxicology - blood |
Measurement of level of substance in blood (procedure) |
Toxoplasma hepatitis |
Hepatitis caused by Toxoplasma gondii |
Toxoplasmosis: [test] or [titre] |
Toxoplasmosis test |
Toy in nose causing respiratory obstruction |
Obstruction of respiratory tract caused by toy in nose (disorder) |
Toy or novelty |
Toy |
Tracheal endoscopy: [diagnostic rigid NOS] or [NEC] |
Endoscopy of trachea using rigid bronchoscope |
Tracheostomy site |
Tracheostomy stoma |
Tracheostomy, emergency procedure by cricothyroid membrane approach |
Emergency cricothyroidotomy |
Traditional therapy |
Complementary therapy |
Trainee manager NOS |
Trainee manager |
Trainee manager NOS |
Trainee manager |
Tramadol hydrochloride 300mg m/r capsule |
Product containing only tramadol in oral dose form (medicinal product form) |
Tramadol hydrochloride 300mg prolonged-release oral capsule |
Product containing only tramadol in oral dose form (medicinal product form) |
Tramadol hydrochloride 50mg soluble tablet |
Product containing precisely tramadol hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Tramazoline hydrochloride+dexamethasone isonicotinate |
Product containing dexamethasone and tramazoline (medicinal product) |
Trandolapril allergy |
Non-allergic hypersensitivity to trandolapril (finding) |
Trandolapril+verapamil hydrochloride |
Product containing trandolapril and verapamil (medicinal product) |
Trandolapril+verapamil hydrochloride 1mg/240mg m/r tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
Trandolapril+verapamil hydrochloride 1mg/240mg prolonged-release oral tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
Trandolapril+verapamil hydrochloride 2mg/180mg m/r tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
Trandolapril+verapamil hydrochloride 2mg/180mg prolonged-release oral tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |